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Abstract
Background: In research laboratories using DNA-microarrays, usually a number of researchers
perform experiments, each generating possible sources of error. There is a need for a quick and
robust method to assess data quality and sources of errors in DNA-microarray experiments. To
this end, a novel and cost-effective validation scheme was devised, implemented, and employed.
Results:  A number of validation experiments were performed on Lactococcus lactis IL1403
amplicon-based DNA-microarrays. Using the validation scheme and ANOVA, the factors
contributing to the variance in normalized DNA-microarray data were estimated. Day-to-day as
well as experimenter-dependent variances were shown to contribute strongly to the variance,
while dye and culturing had a relatively modest contribution to the variance.
Conclusion: Even in cases where 90 % of the data were kept for analysis and the experiments
were performed under challenging conditions (e.g. on different days), the CV was at an acceptable
25 %. Clustering experiments showed that trends can be reliably detected also from genes with
very low expression levels. The validation scheme thus allows determining conditions that could
be improved to yield even higher DNA-microarray data quality.
Background
The development of DNA-microarray technology has ena-
bled genome-wide expression profiling to become a valu-
able tool in the investigation of an organisms' gene
regulation [1-3]. For our studies on gene regulation in
Gram-positive bacteria [4] we use in-house developed
DNA-microarrays containing amplified DNA fragments of
the annotated genes of Lactococcus lactis ssp. lactis IL1403
[5], L. lactis ssp. cremoris MG1363 [6], Bacillus subtilis 168
[7], Bacillus cereus ATCC 14579 [8], and Streptococcus pneu-
moniae TIGR4 [9].
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Standardization of every step in the DNA-microarray pro-
cedure is crucial to correctly and efficiently perform DNA-
microarray experiments, and to obtain reproducible data
[10-13]. In the process from manufacturing DNA-micro-
arrays to performing the actual experiments, systematic
errors and / or bias in the data are introduced in each of
the different steps. The effects of various factors (e.g. dye
and slide) on the quality of DNA-microarray data have
been studied quite extensively albeit for experiments per-
formed with eukaryotic systems [14-20]. In contrast, no
data quality determination has yet been performed on
DNA-microarray data from experiments with bacterial
cultures. Furthermore, the effects of different array batches
or the influence of the experimenter on data quality have
not been included in the previous mentioned experimen-
tal designs. Here, we show that the latter factors are indeed
important for optimizing DNA-microarray data quality.
In order to assess the reproducibility of, and factors
involved in, DNA-microarray data produced in our labo-
ratory during transcriptome analyses by a number of
researchers, a validation experiment was designed and
implemented. This validation scheme is routinely applied
to validate the DNA-microarrays of the various organisms
under study in our group. In addition, it allowed to set a
quality standard as well as to assess sources of errors in the
expression data.
We discuss a novel validation scheme and assess data
quality of a number of validation experiments performed
on amplicon-based DNA-microarrays of L. lactis IL1403.
For any laboratory in which DNA-microarray experiments
are performed on a regular basis, the validation scheme
will provide at the cost of only a few hybridizations, valu-
able information on the DNA-microarray data quality.
Combining multiple validation experiments allows esti-
mation of the main sources of errors.
Results
DNA-microarray quality assessment
Six researchers working with L. lactis IL1403 slides per-
formed nine validation experiments (see Methods and
Figure 1). General statistics on these validation datasets
are listed in Table 1. One has to bear in mind that DNA-
microarrays with lower signals will yield more noisy data,
and thus higher coefficients of variance (CVs). Since these
lower signals might also contain valuable information,
they are included in the analyses described here.
No differentially expressed genes were detected
Differential expression tests were performed for the fac-
tors (supplementary Table S1 [21]; e.g. spot-pins, experi-
menters, and validation experiments), but no genes
The validation procedure Figure 1
The validation procedure. It consists of 4 steps: (i) cell cultur-
ing, (ii) cell pelleting and RNA isolation, (iii) cDNA labeling, 
and (iv) hybridization, scanning, image- and data analysis.
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Table 1: General statistics on data obtained from the validation 
experiments (Figure 1 and supplementary Table S1 [21]).
Validation Validation slide 5 % low spot filter 40 % low spot filter
1 2 3 CV (%) Spots (%) CV (%)
A-I x x x 27.3 89.5 17.4
A-I x 21.6 88.7 13.4
A-I x 26.1 88.9 17.3
A-I x 24.6 91.1 16.5
A x x x 16.4 86 12.5
B x x x 13 84.3 9.4
C x x x 14 94.5 8.6
D x x x 16.7 92.1 11.1
Ex x x 9 . 2 9 0 . 4 6 . 7
F x x x 27.5 87.3 20.2
G x x x 16.5 88.5 10.3
H x x x 23.8 91 15.1
I x x x 18.1 92.2 12.4BMC Genomics 2005, 6:77 http://www.biomedcentral.com/1471-2164/6/77
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meeting the criteria were observed. No differential expres-
sion was expected because the hybridizations were per-
formed with cDNA derived from cells grown under (very)
similar conditions. The resulting expression ratios were
thus close to 1.
CV comparison
The CVs of the validation experiments range from 9 % to
28 % with an average of 17 % and using about 90 % of the
spots. The lower CVs of the 40 % low-intensity-spot-fil-
tered data (Table 1) indicate that a significant part of the
variance originates from genes with low expression. Slides
2 and 3 of each validation experiment (S2 and S3, respec-
tively) examine biological replicates of independent com-
parisons between the cultures A and B (Figure 1). Their
data quality is thus a "worst case scenario" estimate of the
quality to be expected from "real" DNA-microarray exper-
iments as the validation experiments were performed with
a large number of differing parameters: (i) different
researchers performed the experiments, (ii) on different
days, while, lastly, (iii) the cells were harvested in a
growth phase in which small changes in culture optical
density will result in relatively large differences in expres-
sion levels (see below). Table 1 shows, as expected, that
data from the pooled slides 1 of all validation experiments
(S1) have a smaller average CV (22 %) than those of S2
(26 %) and S3 (25 %). The CV frequency distribution for
S1 is shifted towards zero while S2 and S3 have quite sim-
ilar distributions (supplementary Figure S1 [21]) because
of intra-culture differences (Ba or Bb; Figure 1).
Detailed comparison of two slides
The two representative validation experiments, i.e. E and
H, showed clear differences in data quality (supplemen-
tary Table S1 [21]). Box plots of data before the Lowess
grid-based normalization show clear spot pin-dependent
patterns in average signal levels (supplementary Figure S2
[21]). A non-linear intensity-dependent dye-effect in data
from slide E3 (supplementary Figure S2 [21], Graph E2,
(i) is evident from the curved Lowess fits. The Lowess
curves (one curve fitted for each spotted grid; supplemen-
tary Figure S2 [21]) (ii) of slides E3 and H2 are "stacked",
indicative of a grid-dependent gradient of ratios. The
above-mentioned effects are normalized by using the
Lowess grid-based normalization method (supplemen-
tary Figure S2 [21], Graph V).
Gene-dependent fluctuations in ratios and signals
Clustering was performed on the SDs of the ratio-data to
investigate gene-dependent behavior across the validation
experiments (Figure 2). Cluster 1 contains more strongly
expressed genes than cluster 4, with clusters 2 and 3
encompassing genes with intermediate expression levels.
The clustering results were simplified by grouping genes
A first selection of genes was based on the L. lactis IL1403
genome annotation with the underlying assumption that
related genes (either by function or because they are part
of the same operon) are expected to show similar expres-
sion behavior. Only related genes with all members occur-
ring in the same cluster (probability lower than 0.02) were
considered.
Cell growth-related genes show large fluctuations
Clustering revealed that genes with similar SD fluctua-
tions were involved in (i) amino acid biosynthesis, (ii)
energy metabolism, (iii) cell-wall synthesis, and (iv) sal-
vage of nucleosides and nucleotides (Figure 2). Genes
showing highest ratio and signal CVs (supplementary
Table S2 [21]): (i) are of unknown function, (ii) are (pro)
phage-derived, (iii) encode proteins involved in transport
of various compounds, or (iv) encode transcriptional
regulators.
Some genes with low expression show correlated expression 
fluctuations
Figure 3 clearly illustrates that (i) the genes with low
expression have significantly higher CVs than the highly
expressed genes, which is most probably due to their
lower signals, and (ii) the related genes (clustered in Fig-
ure 3) showing similar expression behavior have average
expression levels varying from very low (1.7 % of the max-
imum intensity) to relatively high (65 % of the maximum
intensity). After a close inspection of these (mostly low-
intensity) spots, the fluctuations in ratio and / or expres-
sion levels did not appear to be correlated to spot quality
(data not shown).
ANOVA
A clear correlation between CVs (data quality) and e.g.
array batches or experiments could not be determined.
For instance, validation experiments H and I were per-
formed on the same DNA microarray batch by the same
experimenter, but yielded different CVs. The ANOVA tech-
nique allowed estimating the contribution of several
sources of errors to the total variance in the DNA-microar-
ray data of all slides (Figure 4; S = 1v2v3). The following
factors contributed significantly to the total variance: G
(gene; 5 %; Table 2), VG (validation experiment and gene
interaction; 27 %), SG (slide and gene interaction indica-
tive for dye-effects; 4 %; Table 2), and VSG (validation
experiment, slides, and gene interactions; 31 %).
The VSG interaction detailed
In order to distinguish the separate sources of errors in the
VSG interaction, additional variance analyses were per-
formed with combinations of 2 slides: (i) by omitting
slide 1 (S1; containing a self-hybridization) the VSG inter-
action (S = 2v3) decreased with 7.8 %; (ii) by omittingBMC Genomics 2005, 6:77 http://www.biomedcentral.com/1471-2164/6/77
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slides 2 or 3 (S2 or S3; containing inter-culturing hybridi-
zations) the VSG  interaction (S  = 1v2 or S  = 1v3)
decreased with 9.4 % and 9.1 %, respectively; and (iii) the
decrease in the VSG  interactions coincides with an
increase of the VG  interaction. This leads to the
conclusion that variances occur on each slide (Gene ×
Array; Table 2) and may, in part, be due to hybridization
effects. Since the variance for a particular slide (7.8 %) is
omitted from the variance analyses, the VSG interaction
will decrease, but the VG interaction will increase (the 7.8
% variance was specific for the slide that was omitted from
the analyses). This 7.8 % variance is assumed to be the
same for each of the three slides. The larger effect of S2
and S3 compared to S1 in the VSG interaction is probably
caused by the fact that on these slides inter-culture com-
parisons were performed. Since dye-effects are assumed to
be global, it can be concluded that the intra-culturing dif-
ferences (differences between the Ba  and Bb  cultures)
account for the 1.6 and 1.3 % larger decrease in the VSG
interaction (by omitting S2 or S3, respectively). The vari-
ance introduced by the Ba and Bb cultures is quite repro-
ducible (1.3 – 1.6 %) and is caused by RNA isolation and
labeling (Table 2).
Slide and sampling differences can be determined from VSG
The variance of S1 versus the pooled S2 and S3 (S = 1v23)
in the VSG interaction decreased with 16.1 % to 14.9 %,
with the variance in the VG interaction remaining virtu-
ally unchanged. By combining S2 and S3, the Gene ×
Array interactions occurring specifically on S2 and S3 are
pooled. They are, thus, not accommodated in the VG
interaction, but rather in the residual error. The remaining
14.9 % variance in the VSG interaction still contains the
Gene × Array interactions for S1 (7.8 %) and sampling dif-
ferences (7.1 %; Table 2).
Day-to-day differences are most prominent in the VG interaction
The VG interaction contains differences between valida-
tion experiments (Figure 4): the DNA microarray batch
used (BG), day-to-day differences (AG), the researcher
Sammon projection of the clustering of validation data using a self-organizing Kohonen map Figure 2
Sammon projection of the clustering of validation data using a self-organizing Kohonen map. Validation experiments (A-I) are 
shown as well as the clusters (1 – 4; consisting of 761, 230, 227, 886 genes, respectively). Operon names, the number of mem-
bers, and their (putative) functions are listed to the right of the corresponding clusters. The minimum number of genes in an 
operon of which all members should be in a certain cluster was determined at a probability of 0.02 or lower for clusters 1 (4 
genes), 2 (2 genes), 3 (2 genes), and 4 (5 genes).
atp
nif
nrd
pbp
pot
pro
ybg
ybj
yia
but
tru
ybc
dac
fad
nap
glp
yai
ymb
yoa
yqc
yvi
 (7) ATP synthase alpha subunit
 (4) Energy metabolism, electron transport
(4) Salvage of nucleosides and nucleotides
 (4) Cell envelope, murein sacculus and peptidoglycan
 (4) Transport and binding protein; amino acids, peptides and amines
 (4) Glutamate family; Proline biosynthesis pathway
 (4) Unknown
 (5) Unknown
(4) Unknown; aerobic energy metabolism
 (2) Energy metabolism; fermentation
 (2) tRNA modification
 (3) Unknown
 (2) Final stages in peptidoglycan synthesis
 (2) Fatty acid and phospholipid metabolism
 (2) Unknown; multidrug-efflux transporter
(5) Anaerobic energy metabolism; glycerol utilization pathway
 (7) Hypothetical protein
(5) Unknown; transposon related
(6) Unknown; transport and binding protein, cation
 (7) Unknown
 (6) Unknown; energy metabolism, electron transport
 A  B  C D E F G  H IBMC Genomics 2005, 6:77 http://www.biomedcentral.com/1471-2164/6/77
Page 5 of 10
(page number not for citation purposes)
performing the experiment (PG), and spot-pin / RNA iso-
lation method used (DU). Due to confounding of these
factors, a less efficient estimation of their relative contri-
butions was unavoidable. However, the contributions of
BG, PG, AG, DU in relation to the VG interaction could be
determined (Table 2). The day-to-day differences were
estimated to have the largest contribution to the variance,
followed by experimenter, the DNA microarray batch, and
lastly a relatively low contribution of switching the RNA
isolation method (coinciding with a change from 8 to 12
spot-pins).
Discussion
The validation procedure presented here was imple-
mented to provide a standardized method to assess DNA-
microarray data quality generated in our laboratory and
should be well-suited for use in other laboratories. A
workable trade-off between costs, time investment, and
data-quality was obtained by using only three DNA-
microarray slides for each validation experiment. This
scheme is suitable for identifying factors that yield "unre-
liable" data (i.e. data with ratios that deviate from 1 due
to, for instance, outliers). In a number of cases, the
Plot of percentage of maximal intensity versus CV values calculated for the expression levels of genes in the 9 validation data- sets (dark-blue small squares) Figure 3
Plot of percentage of maximal intensity versus CV values calculated for the expression levels of genes in the 9 validation data-
sets (dark-blue small squares). Purple solid triangles show the top 40 genes with highest variability in ratio and signals (supple-
mentary Table S2 [21]). Functionally related genes showing validation experiment-dependent SDs (Figure 2) are indicated by 
cluster 1 (solid yellow circles), cluster 2 (open light-blue triangles), cluster 3 (open red squares), and cluster 4 (open green 
circles).
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validation experiment even identified experimenters who
did not flag bad spots stringently enough.
Assessment of high-throughput gene expression data
quality is a challenging task. A potential problem arises
from the fact that many studies do not describe in detail
the resulting amount of data on which statistic analyses
was based. This information is, however, crucial to deter-
mine data-quality. To demonstrate the effect of filtering
on data quality, statistics were also calculated for data in
which 40 % of the lowest intensity spots were removed
(Table 1). These rigorously filtered data do show
improved data quality, but at the expense of many meas-
urements that could contain valuable information. The 5
% low-intensity spot filter employed in our study was
selected after careful examination of data from various
DNA-microarray experiments performed in our labora-
tory. Some targets with low expression levels allowed
grouping genes by function, revealing trends that would
have been difficult to discern with more rigorous filtering.
A thorough discussion of these results is, however, outside
the scope of this study.
The data quality of the validation experiments described
in this paper proved to be satisfactory, while at same time
a maximum amount of data was preserved. One has to
bear in mind that a significant part of the variance in our
data is caused by varying factors (e.g. differences in the
days on which the experiments were performed; discussed
in more detail below). In addition, the quality of the glass
surfaces used in this study was lower than that of presently
used superamine glass slides (Telechem International
Inc.). Together with recently implemented increased strin-
gency of clean-room rules, this will increase data-quality
even more. The average CV value for the validation
experiments was 26.1 % and 24.6 % for S2 and S3 with
use of 90 % of the spots (Table 1). These results are com-
parable to CVs, ranging from 11 to 23 %, reported for a
number of studies using cDNA derived from eukaryotic
cell cultures hybridized on various DNA microarray plat-
forms [20,22,23]. For other DNA-microarray experiments
performed in our laboratory the data quality is considera-
bly higher (average CVs of under 20 %) stipulating that in
effect, the average CV of about 25 % described in this
study is an underestimation of the data quality one could
obtain.
By mining the data from several validation datasets it was
possible to determine which factors contribute to the var-
iance in normalized DNA-microarray data. The following
factors were identified (Figure 4 and Table 2): (i) valida-
tion experiments (VG; 27 %), (ii) sampling (7 %), (iii)
Array × Gene (8 %), gene variances (5 %), and dye-effects
(4 %). The contributions of RNA isolation and labeling to
the variance were quite low (1.5 %; Table 2). Additional
ANOVA results Figure 4
ANOVA results. Each bar represents averages (with error 
bars signifying the standard deviations for the respective 
interactions) for 10 random samples of ratio data obtained 
for the indicated slide combinations (1, 2, and 3; Figure 1). 
E.g. S = 1v2 indicates a comparison of data from slides 1 with 
data from slides 2. The interactions (indicated by the colored 
bars as detailed in the inset) and "Error" (residual variance) 
amount to 100 % (the total variance present in the data).
Table 2: Contribution of sources to the variance estimated for 
the nine validation experiments (Figure 4) and contribution of 
individual factors to the VG interactiona.
Variance source Contribution to the variance (%)
Gene (G)5 . 0
Dye (SG)4 . 2
Gene × Arrayb 7.8
RNA isolation and labelingc 1.5
Sampling 7.1
VGd 26.9
Day × Gene 19.7e
Experimenter × Gene 17.3e
Array batch × Gene 14.9e
Spot pins × Gene 4.5f
a The degrees of freedom results in the separate ANOVAs are listed 
in the supplementary web-site [21].
b Assumed to consist of hybridization effects and signal-to-noise 
differences per slide.
c Derived from the variance observed between Ba and Bb cultures 
(Figure 1).
d Variances that are dependent on the validation experiment 
performed and due to day-to-day differences, identity of the 
experimenter, and DNA microarray batch differences.
e Due to overlap in levels, the contribution of these interactions were 
individually determined.
f A change from 8 to 12 spot-pins used for array spotting coincided 
with a switch in the RNA isolation method.
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variance analyses showed that the day-to-day differences
contribute most to the 27 % variance observed for the VG
interaction, followed by the experimenter, the DNA
microarray batch, and lastly a change in the RNA isolation
method (coinciding with the use of arrays spotted with 12
instead of 8 spot-pins). The contribution of dye-effects
was determined to be only 4 %, which is low compared to
the contribution of dye-effects determined for in studies
from Chen et al. and Dombrowski et al. [18,24]. The latter
study describes the use of a direct labeling kit. In contrast,
indirect labeling was used in our study, in which differen-
tial hybridization of Cy3 and Cy5-labeled cDNA is antici-
pated. Direct-labeling adds, next to this differential
hybridization, (i) preference of the reverse transcriptase
enzyme for the Cy3 label and (ii) prolonged exposure to
air and light of the dyes increasing the chance of oxidation
and / or bleaching. The main contributing factors identi-
fied in this study are in agreement with a number of stud-
ies involving cDNA derived from eukaryotic tissue
cultures [18,19,25]. In contrast to these studies, we were
able to attribute a relatively large contribution of the total
variance to specific sources of errors (67 %) because of the
efficient design of the validation experiment described
here. Since the contributions of day-to-day variation,
DNA microarray batch differences, and the experimenter
to the variance amounted up to 27 %, it can be concluded
that even higher data-quality can be obtained when exper-
iments are performed under identical conditions.
The ANOVA model used does not account for gene-to-
gene variances. Additional variance analyses were per-
formed with datasets of which the 10 % most noisy genes
(with highest CVs) were omitted. In these experiments,
the relative contribution of the various factors identified
above remained unchanged (results not shown), indicat-
ing that the proposed procedure is robust and that its
results are not dependent on a relatively small portion of
noisy genes.
In this paper, data from hybridizations with RNA derived
from the same experimental conditions were used. To
examine whether the probes used on the slides are correct
and whether observed gene expression levels are accurate,
experiments should be carried out which measure known
differentially expressed genes. A number of such studies in
which targets were identified by DNA-microarray experi-
ments (e.g. on arginine and glucose metabolism and on
nisin resistance development), and subsequently verified
by alternative techniques (real-time PCR, gene knock-out
and / or overexpression studies), have successfully been
performed in our laboratory (results not shown).
The validation experiments described in this study were
designed to be a "worst case scenario." Data quality
proved to be good even though they were obtained at
challenging conditions: (i) flask-grown cells, (ii) harvest-
ing in a growth phase in which relatively large changes in
gene-expressions occur, and (iii) change of factors (e.g.
day). These factors represent the conditions under which
DNA microarray experiments are performed in our
laboratory. Another laboratory could have different fac-
tors and levels: e.g. only one researcher that performs the
experiments or a different organism under study. Such a
laboratory should perform the validation experiments to
determine the contribution of the factors that play a role
in their particular case. The results of clustering indicate
that functionally related genes share specific behaviour
across the validation experiments (Figure 3). The signifi-
cant expression levels and relatively large fluctuations in
ratios of the ybg, ybj, and yia gene groups are probably due
to biological variations (growth-phase and medium-batch
related). Furthermore, one can conclude that data from
even genes with very low expression can reveal interesting
trends. By preserving the maximum amount of data, one
might be able to discern more subtle differences in expres-
sion levels of genes with low expression.
Conclusion
In this paper a novel validation scheme was employed to
assess data quality and sources of errors of DNA-microar-
rays. Even in the case that 90 % of the data were preserved
and the experiments were performed at challenging con-
ditions, the coefficient of variance was at an acceptable 25
%. Clustering experiments showed that trends could be
detected from genes with very low expression. Using
ANOVA, day-to-day as well as experimenter-dependent
variances were found to contribute strongly to the vari-
ance, while dye and culturing contributions to the vari-
ance were relatively modest. The validation scheme thus
allows determining conditions that could be used to
obtain DNA-microarray data of improved quality.
Methods
DNA-microarray experimental procedures
DNA-microarrays were prepared from amplicons of 2108
genes in the genome of Lactococcus lactis ssp. lactis IL1403
(Genbank accession number NC_002662; its annotation
is based on the B. subtilis genome, Genbank accession
number NC_000964). Primers were designed to amplify
unique regions of these genes [26]. Generation of the
amplicons, slide spotting, slide treatment after spotting,
and slide quality control were performed as described [4]
with modifications (see protocols at supplementary web-
site [21]). Samples for RNA isolation were taken by rapid
sampling of exponentially growing cultures of L. lactis.
Methods for cell disruption, RNA isolation, RNA quality
control, complementary DNA (target) synthesis, indirect
labeling, hybridization, and scanning are described in the
supplementary web-site [21].BMC Genomics 2005, 6:77 http://www.biomedcentral.com/1471-2164/6/77
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Validation experiment
The validation experiment (Figure 1) was designed as fol-
lows: two independent cultures of L. lactis ssp.  lactis
IL1403 were grown at 30°C to an optical density at 600
nm (OD600) of 2.0 / cm (corresponding to end-log phase)
in standing flasks with 50 mL M17 medium [27] contain-
ing 0.5 % glucose (w/v). A 10 mL sample was taken from
one of these cultures, while from the other culture two
samples of 10 mL were withdrawn. For the validation
experiments (supplementary Table S1 [21]), total RNA
was extracted using the RNA isolation methods with and
without macaloid, for slides made with 12 spot pins and
8 spot pins, respectively. The cDNAs were labeled accord-
ing to the scheme in Figure 1. The mRNA derived from the
A culture was labeled once with Cy3 and three times with
the Cy5 dye. The mRNA derived from the Ba and Bb cul-
tures were both labeled with the Cy3 dye. Finally, the
labeled cDNAs were hybridized on L. lactis IL1403 DNA-
microarrays (Figure 1).
Data processing
Slide data were processed by using MicroPreP [28,29]. (i)
spots that were bad (for instance due particles on the slide
surface) were manually flagged (for an example see sup-
plementary Figure S3 [21]). These flagged spots were
deleted from the datasets because they yield unreliable
measurements; (ii) since the spotting buffer contains
small random DNA fragments, spots will always have a
base signal, particularly in the Cy3 channel, due to
autofluorensence of these fragments. The spot back-
grounds in each grid for both channels were corrected for
this autofluorescense by subtracting the intensity of the
weakest spot; (iii) the 5 % or 40 % weakest spots (sum of
Cy3 and Cy5 net signals) were deleted. The effect of filter-
ing low-intensity spots from the datasets is demonstrated
in supplementary Figure S4 [21]. The 5 % cutoff was deter-
mined empirically: the most noisy data is removed from
the datasets without removing reliable data; (iv) normali-
zation was performed (the ratios were made comparable
across slides) using a grid-based Lowess transformation
[30] with f = 0.5 (fraction of genes to use); (v) for both
channels the intensities of the "Lowess" fraction of genes
were added to yield a total signal, and all intensities were
divided by this total signal, yielding scaled, arbitrary
expression levels. One has to bear in mind that the scaling
procedure affects the signals, but not the ratios. Since the
statistical procedures in this paper are based on the ratios,
scaling does not affect these analyses; (vi) tables for vari-
ance analyses were made. These tables list for each meas-
urement the factors and their levels (see also
supplementary Table S1 [21]). For example: spot 1 of slide
1 of validation experiment 1 is gene X (from the gene fac-
tor), was obtained by experimenter Y (from the factor
experimenter), on day Z (from the factor day).
The scanned images, data, and experimental conditions
were stored in the MIAME-compliant Molecular Genetics
Information System (MolGenIS) [31].
Statistical procedures and clustering
The quality of the validation datasets discussed in this
paper are presented by coefficient of variance (CV). CVs
are calculated by dividing the standard deviation (SD) by
the mean ratio of a gene and multiplying by 100 %. The
minimum and maximum numbers of measurements for
each gene were 13 and 54 (i.e. 9 validation experiments ×
3 slides per validation experiment × 2 technical replicates
per slide), respectively. For single validation experiments,
CVs and differential expression levels were determined for
genes for which at least 4 measurements were available.
Differential expression tests were performed with the
Cyber-T implementation of a variant of the t-test [32].
These tests yield for each gene the probability that it has a
significantly different ratio than 1. Due to that multiple
tests for differential expressions were performed, the false
discovery rate (FDR) was determined. The FDR represents
the probability that a significant differentially expressed
gene is in fact false-positive. FDRs were calculated by (i)
ranking the genes by p-value, (ii) multiplying the p-values
with the number of tests performed (similar to Bonferroni
correction), and (iii) dividing by the number of genes
with lower p-values. Genes were considered differentially
expressed at both p < 0.01 and FDR < 0.01.
The SDs of log (base 2)-transformed ratios were used for
clustering purposes. The clustering technique groups
genes which SDs are similar across the validation experi-
ments. The values of SDs for genes with less than four
measurements were interpolated by using the K-nearest
two neighbours approach using Engene [33]: only four
genes which lacked the first or last SD had to be omitted.
For each gene, SDs were centered after which clustering
was performed using the Kohonen self-organizing map
(SOM) algorithm (2 × 2 matrix) in the Engene clustering
package.
ANOVA
The statistical software package SPSS (version 11; SPSS
Inc., Chicago, IL) was used to perform variance analyses
(ANOVA). ANOVA determines the contributions of fac-
tors (e.g. day) and their levels (e.g. an experiment per-
formed on Monday) to the total variance observed in the
datasets. Supplementary Table S1 [21] presents factors
and their levels used for ANOVA.
ANOVA is robust with respect to violations
The assumptions of ANOVA that (i) error variances are
equal and (ii) the residuals of the model are normally dis-
tributed generally do not hold for DNA microarray data.BMC Genomics 2005, 6:77 http://www.biomedcentral.com/1471-2164/6/77
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However, the sole purpose of ANOVA for this paper was
to estimate the relative contributions of the various fac-
tors, a purpose for which ANOVA is extremely robust. If
the error variances are not equal, the estimators for the
type III sums of squares of the various factors, although
less efficient, are still valid and unbiased [34]. Further-
more, the efficiency reduces most when the ANOVA
design is very unbalanced and/or random factors are
implemented [35]. In our case, the design is quite bal-
anced and a fixed-factors model is used. The relative sums
of squares are used instead of p-values, because the latter
might be violated by deviations from the assumptions.
A whole-slide model was chosen over a gene-by-gene model
When performing variance analyses on DNA-microarray
data, one can either use a whole-slide model or a more
complicated model that allows for gene-to-gene differ-
ences. Gene-by-gene models can deal better with vari-
ances that are gene-dependent (due to differences in gene
expression levels). However, as each of the three hybrid-
ized slides (Figure 1) contains different combinations of
cDNAs derived from the A and B cultures, the gene expres-
sion levels are expected to differ from slide-to-slide, ren-
dering the gene-by-gene method less effective than our
whole-slide model.
Genes were randomly selected for ANOVA
The software could not handle a gene factor of 2108 levels
(genes) and additional interactions in model (1). To
reduce data dimensions, we chose to randomly select
genes instead of other methods (e.g. grouping of genes
based on clustering or function) because the latter depend
on assumptions of which the validity for the datasets are
difficult to determine. The selection was repeated 10 times
(with 5 % or 105 random genes each time) yielding 1050
genes of which 196 were drawn two or more times. These
854 uniquely selected genes (40.5 % of the total genes)
corresponded well to the predicted 40.0 % (calculated by
[1 - (((2108-105) / 2108)10)]). The sums of squares were
averaged for the sources (i.e. factors) contributing signifi-
cantly to the variance (α  = 0.05).
The ANOVA model uses log-transformed ratio data
Attempts to identify the sources of errors and their contri-
butions to the variance based on signal data, proved to be
unsuccessful due to large differences in gene expression
levels. A similar observation has been made for oligonu-
cleotide-based DNA-microarrays hybridized with liver tis-
sue RNA [17]. For this reason, we used the following
ANOVA model:
rigpbtv = µ + Si + Gg + Aa + Pp + Bb + Tt + Vv + Uu + (VG)vg +
(SG)ig + (VSG)vig + ε igpbtv   (1)
where rigpbtv is the log (base 2)-transformed ratio of gene g,
which is the tth replicate spot on slide i  performed by
experimenter p on array batch b which was spotted with u
spot pins (either 8 or 12) in validation experiment v. rigpbtv
is determined by µ (the mean ratio across all the factors)
and the global factors slide (S), experimenter (P), array
batch (B), day (A), the validation experiment (V), repli-
cate spot (T; 1 or 2), the number of spot pins used (U),
and a residual error (ε igpbtv). Dye-effects are assumed to be
in the SG interaction: they are global although the relative
contributions of slides 1 – 3 might differ since only slide
1 contains a self-hybridization. The VSG interaction con-
tains variances due to hybridization and sampling.
Some factors are confounded
Due to the fact that in our DNA-microarray laboratory val-
idation experiments are only performed when necessary
(i.e. to introduce a new scientist (experimenter) in the lab-
oratory) confounding of some factors could not be
avoided. Therefore, variance analyses were performed by
employing the validation experiment (VG) interaction
which incorporates: experimenter (PG), array batch (BG),
day (AG), and the number of spot pins, coinciding with a
change in RNA isolation method (GU).
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